Skip to content
1887

Microbial Genomics logo Microbial Genomics

Volume 11, Issue 11

Global transcriptional reprogramming by cytomegalovirus infection suppresses MHC class II antigen presentation while enhancing migration machinery in murine dendritic cells Open Access

Abstract

Dendritic cells (DCs) serve dual roles in cytomegalovirus infection: orchestrating antiviral immunity and acting as vehicles for viral dissemination. DC-dependent systemic spread of mouse cytomegalovirus (MCMV) is dependent on the expression of a viral G protein-coupled receptor homologue, encoded by M33. We performed global transcriptional profiling of murine DCs infected with either WT mouse MCMV or an M33 mutant harbouring a single point mutation (R131Q; denoted M33NQY), which ablates constitutive G protein-dependent signalling. RNA-seq analysis revealed that MCMV induces substantial transcriptional reprogramming, with over 2,400 significantly altered genes affecting key immune and migration pathways. WT MCMV infection resulted in 1,883 upregulated and 658 downregulated genes, while M33NQY infection showed comparable effects with 1,905 upregulated and 668 downregulated genes. Both viruses systematically downregulated the MHC class II antigen presentation machinery, with substantial suppression of H2 molecules, peptide-loading components () and the class II transactivator (log₂FC >−6.4). Pathway analysis revealed coordinated disruption of B cell receptor signalling, leucocyte transendothelial migration and antigen processing and presentation. A comparison between WT and M33NQY-infected DCs demonstrated that while both viruses similarly impair antigen presentation, M33 signalling specifically enhances the expression of genes involved in transendothelial migration, including (osteopontin, log₂FC=0.65), cytoskeletal components ( and ), adhesion molecules () and matrix interaction factors ( and ). Network analysis identified critical hub genes, including , , and , as key regulatory nodes connecting antigen presentation and migration pathways. This provides molecular evidence for a sophisticated viral strategy that shields MCMV from immune detection while hijacking DC migratory machinery to facilitate dissemination, with M33 serving as a specific enhancer of migration-related pathways.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): cytomegalovirus , dendritic cells , immune evasion , leucocyte migration , mouse cytomegalovirus (MCMV) , transcriptome , transendothelial migration and viral dissemination
Funding
This study was supported by the:
  • Australian Research Council (Award DP190101851)
    • Principal Award Recipient: HelenE. Farrell
  • National Health and Medical Research Council of Australia (Award 1140169)
    • Principal Award Recipient: HelenE. Farrell
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001563
2025-11-25
2025-12-16

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/mgen/11/11/mgen001563.html?itemId=/content/journal/mgen/10.1099/mgen.0.001563&mimeType=html&fmt=ahah

References

  1. Parry RH, McMillan C, Bruce KL, Farrell HE. Global transcriptional reprogramming by cytomegalovirus infection suppresses MHC class II antigen presentation while enhancing migration machinery in murine dendritic cells. Figshare 2025
     [Google Scholar]
  2. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245–252 [View Article] [PubMed]
     [Google Scholar]
  3. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013; 31:563–604 [View Article] [PubMed]
     [Google Scholar]
  4. Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol 2007; 25:381–418 [View Article] [PubMed]
     [Google Scholar]
  5. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 2005; 5:617–628 [View Article] [PubMed]
     [Google Scholar]
  6. Förster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008; 8:362–371 [View Article] [PubMed]
     [Google Scholar]
  7. Sozzani S, Allavena P, D’Amico G, Luini W, Bianchi G et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 1998; 161:1083–1086 [PubMed]
     [Google Scholar]
  8. Bajénoff M, Egen JG, Koo LY, Laugier JP, Brau F et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 2006; 25:989–1001 [View Article] [PubMed]
     [Google Scholar]
  9. Sixt M, Kanazawa N, Selg M, Samson T, Roos G et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 2005; 22:19–29 [View Article] [PubMed]
     [Google Scholar]
  10. Guermonprez P, Valladeau J, Zitvogel L, Théry C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002; 20:621–667 [View Article] [PubMed]
     [Google Scholar]
  11. Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 2006; 6:476–483 [View Article]
     [Google Scholar]
  12. Allavena P, Sica A, Vecchi A, Locati M, Sozzani S et al. The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol Rev 2000; 177:141–149 [View Article] [PubMed]
     [Google Scholar]
  13. Garg S, Oran A, Wajchman J, Sasaki S, Maris CH et al. Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat Immunol 2003; 4:907–912 [View Article] [PubMed]
     [Google Scholar]
  14. Ingulli E, Mondino A, Khoruts A, Jenkins MK. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. J Exp Med 1997; 185:2133–2141 [View Article] [PubMed]
     [Google Scholar]
  15. Kamath AT, Henri S, Battye F, Tough DF, Shortman K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002; 100:1734–1741 [PubMed]
     [Google Scholar]
  16. Luber CA, Cox J, Lauterbach H, Fancke B, Selbach M et al. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 2010; 32:279–289 [View Article] [PubMed]
     [Google Scholar]
  17. Miller JC, Brown BD, Shay T, Gautier EL, Jojic V et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol 2012; 13:888–899 [View Article]
     [Google Scholar]
  18. Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 2001; 97:3171–3176 [View Article] [PubMed]
     [Google Scholar]
  19. Sinclair JH, Reeves MB. Human cytomegalovirus manipulation of latently infected cells. Viruses 2013; 5:2803–2824 [View Article] [PubMed]
     [Google Scholar]
  20. Boeckh M, Geballe AP. Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest 2011; 121:1673–1680 [View Article] [PubMed]
     [Google Scholar]
  21. Griffiths P, Baraniak I, Reeves M. The pathogenesis of human cytomegalovirus. J Pathol 2015; 235:288–297 [View Article] [PubMed]
     [Google Scholar]
  22. Reeves MB, Sinclair JH. Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo. J Virol 2013; 87:10660–10667 [View Article] [PubMed]
     [Google Scholar]
  23. Sinclair J, Sissons P. Latency and reactivation of human cytomegalovirus. J Gen Virol 2006; 87:1763–1779 [View Article]
     [Google Scholar]
  24. Shnayder M, Nachshon A, Rozman B, Bernshtein B, Lavi M et al. Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte state. Elife 2020; 9:e52168 [View Article] [PubMed]
     [Google Scholar]
  25. Yunis J, Farrell HE, Bruce K, Lawler C, Sidenius S et al. Murine cytomegalovirus degrades MHC class II to colonize the salivary glands. PLoS Pathog 2018; 14:e1006905 [View Article] [PubMed]
     [Google Scholar]
  26. Bruce K, Ma J, Lawler C, Xie W, Stevenson PG et al. Recent advancements in understanding primary cytomegalovirus infection in a mouse model. Viruses 2022; 14:1934 [View Article] [PubMed]
     [Google Scholar]
  27. Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S. Pathogenesis of murine cytomegalovirus infection. Microbes Infect 2003; 5:1263–1277 [View Article] [PubMed]
     [Google Scholar]
  28. Farrell HE, Lawler C, Tan CSE, MacDonald K, Bruce K et al. Murine cytomegalovirus exploits olfaction to enter new hosts. mBio 2016; 7:e00251–16 [View Article] [PubMed]
     [Google Scholar]
  29. Farrell HE, Lawler C, Oliveira MT, Davis-Poynter N, Stevenson PG. Alveolar macrophages are a prominent but nonessential target for murine cytomegalovirus infecting the lungs. J Virol 2015; 90:2756–2766 [View Article] [PubMed]
     [Google Scholar]
  30. Farrell HE, Bruce K, Lawler C, Oliveira M, Cardin R et al. Murine cytomegalovirus spreads by dendritic cell recirculation. mBio 2017; 8:e01264-17 [View Article] [PubMed]
     [Google Scholar]
  31. Ma J, Bruce K, Stevenson PG, Farrell HE. Murine cytomegalovirus MCK-2 facilitates in vivo infection transfer from dendritic cells to salivary gland acinar cells. J Virol 2021; 95:e0069321 [View Article] [PubMed]
     [Google Scholar]
  32. Saederup N, Lin Y chun, Dairaghi DJ, Schall TJ, Mocarski ES. Cytomegalovirus-encoded β chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci USA 1999; 96:10881–10886 [View Article]
     [Google Scholar]
  33. Suvas S, Rouse BT. Treg control of antimicrobial T cell responses. Curr Opin Immunol 2006; 18:344–348 [View Article] [PubMed]
     [Google Scholar]
  34. Andrews DM, Andoniou CE, Granucci F, Ricciardi-Castagnoli P, Degli-Esposti MA. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol 2001; 2:1077–1084 [View Article] [PubMed]
     [Google Scholar]
  35. Mathys S, Schroeder T, Ellwart J, Koszinowski UH, Messerle M et al. Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. J Infect Dis 2003; 187:988–999 [View Article] [PubMed]
     [Google Scholar]
  36. Loewendorf A, Benedict CA. Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything. J Intern Med 2010; 267:483–501 [View Article] [PubMed]
     [Google Scholar]
  37. Cardin RD, Schaefer GC, Allen JR, Davis-Poynter NJ, Farrell HE. The M33 chemokine receptor homolog of murine cytomegalovirus exhibits a differential tissue-specific role during in vivo replication and latency. J Virol 2009; 83:7590–7601 [View Article] [PubMed]
     [Google Scholar]
  38. Davis-Poynter NJ, Lynch DM, Vally H, Shellam GR, Rawlinson WD et al. Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J Virol 1997; 71:1521–1529 [View Article] [PubMed]
     [Google Scholar]
  39. Lemmermann NAW, Böhm V, Holtappels R, Reddehase MJ. In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models. Virus Res 2011; 157:161–174 [View Article] [PubMed]
     [Google Scholar]
  40. Lee AW, Wang N, Hornell TMC, Harding JJ, Deshpande C et al. Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels. Mol Immunol 2011; 48:1160–1167 [View Article] [PubMed]
     [Google Scholar]
  41. Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H et al. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J 1999; 18:1081–1091 [View Article] [PubMed]
     [Google Scholar]
  42. Tomazin R, Boname J, Hegde NR, Lewinsohn DM, Altschuler Y et al. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med 1999; 5:1039–1043 [View Article] [PubMed]
     [Google Scholar]
  43. Ziegler H, Thale R, Lucin P, Muranyi W, Flohr T et al. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 1997; 6:57–66 [View Article] [PubMed]
     [Google Scholar]
  44. Fleming P, Davis-Poynter N, Degli-Esposti M, Densley E, Papadimitriou J et al. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J Virol 1999; 73:6800–6809 [View Article] [PubMed]
     [Google Scholar]
  45. Case R, Sharp E, Benned-Jensen T, Rosenkilde MM, Davis-Poynter N et al. Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo. J Virol 2008; 82:1884–1898 [View Article] [PubMed]
     [Google Scholar]
  46. Farrell HE, Bruce K, Lawler C, Oliveira M, Cardin R et al. Murine cytomegalovirus spreads by dendritic cell recirculation. mBio 2017; 8:01264–17 [View Article] [PubMed]
     [Google Scholar]
  47. Wickham H, Averick M, Bryan J, Chang W, McGowan LD’Agostino et al. Welcome to the tidyverse. JOSS 2019; 4:1686 [View Article]
     [Google Scholar]
  48. Wickham H. Ggplot2: Elegant Graphics for Data Analysis, 2nd Edn New York: Springer; 2009 [View Article]
     [Google Scholar]
  49. Cheng X, Yan J, Liu Y, Wang J, Taubert S. eVITTA: a web-based visualization and inference toolbox for transcriptome analysis. Nucleic Acids Res 2021; 49:W207–W215 [View Article] [PubMed]
     [Google Scholar]
  50. Sancho D, Joffre OP, Keller AM, Rogers NC, Martínez D et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009; 458:899–903 [View Article]
     [Google Scholar]
  51. Zelenay S, Keller AM, Whitney PG, Schraml BU, Deddouche S et al. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice. J Clin Invest 2012; 122:1615–1627 [View Article]
     [Google Scholar]
  52. Zhang J-G, Czabotar PE, Policheni AN, Caminschi I, San Wan S et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity 2012; 36:646–657 [View Article]
     [Google Scholar]
  53. Ma J, Bruce K, Davis-Poynter N, Stevenson PG, Farrell HE. The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of in vivo infection via distinct components of its signaling repertoire. J Virol 2022; 96:e0186721 [View Article] [PubMed]
     [Google Scholar]
  54. Renkl AC, Wussler J, Ahrens T, Thoma K, Kon S et al. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 2005; 106:946–955 [View Article] [PubMed]
     [Google Scholar]
  55. Maussang D, Langemeijer E, Fitzsimons CP, Stigter-van Walsum M, Dijkman R et al. The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res 2009; 69:2861–2869 [View Article] [PubMed]
     [Google Scholar]
  56. Vomaske J, Melnychuk RM, Smith PP, Powell J, Hall L et al. Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility. PLoS Pathog 2009; 5:e1000304 [View Article] [PubMed]
     [Google Scholar]
  57. Le Roy E, Mühlethaler-Mottet A, Davrinche C, Mach B, Davignon JL. Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression. J Virol 1999; 73:6582–6589 [View Article] [PubMed]
     [Google Scholar]
  58. Farrell HE, Bruce K, Lawler C, Stevenson PG. Murine cytomegalovirus spread depends on the infected myeloid cell type. J Virol 2019; 93:e00540-19 [View Article] [PubMed]
     [Google Scholar]
  59. Huang W-C, Havel JJ, Zhau HE, Qian WP, Lue H-W et al. Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells. Clin Cancer Res 2008; 14:5341–5347 [View Article] [PubMed]
     [Google Scholar]
  60. Waldhoer M, Kledal TN, Farrell H, Schwartz TW. Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J Virol 2002; 76:8161–8168 [View Article] [PubMed]
     [Google Scholar]
  61. Melnychuk RM, Streblow DN, Smith PP, Hirsch AJ, Pancheva D et al. Human cytomegalovirus-encoded G protein-coupled receptor US28 mediates smooth muscle cell migration through Galpha12. J Virol 2004; 78:8382–8391 [View Article] [PubMed]
     [Google Scholar]
  62. White TM, Bonavita CM, Stanfield BA, Farrell HE, Davis-Poynter NJ et al. The CMV-encoded G protein-coupled receptors M33 and US28 play pleiotropic roles in immune evasion and alter host T cell responses. Front Immunol 2022; 13:1047299 [View Article]
     [Google Scholar]
  63. Icer MA, Gezmen-Karadag M. The multiple functions and mechanisms of osteopontin. Clinical Biochemistry 2018; 59:17–24 [View Article]
     [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.001563
Loading
Global transcriptional reprogramming by cytomegalovirus infection suppresses MHC class II antigen presentation while enhancing migration machinery in murine dendritic cells
M Gen 11, 001563 (2025); https://doi.org/10.1099/mgen.0.001563
/content/journal/mgen/10.1099/mgen.0.001563
/content/journal/mgen/10.1099/mgen.0.001563
Loading

Data & Media loading...

Supplements

Loading data from figshare Loading data from figshare

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error